CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Revenues:
Total revenues	$ 213,194	$ 205,994
Operating expenses:
Research and development - intellectual property acquired		116,044,886
Research and development	12,764,804	7,952,870
General and administrative	9,977,196	24,379,871
Total operating expenses	22,742,000	148,377,627
Loss from operations	(22,528,806)	(148,171,633)
Other income (expense):
Change in fair value of warrant liabilities	18,000	(40,000)
Interest income	1,082,842	253,723
Net loss	$ (21,427,964)	$ (147,957,910)
Net loss per share, basic and diluted	$ (0.47)	$ (7.75)
Weighted average number of common shares outstanding	45,587,734	19,091,926
Grant income
Revenues:
Total revenues	$ 213,194	$ 205,994